D G Harper
Overview
Explore the profile of D G Harper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Volicer L, Harper D, Stopa E
J Nutr Health Aging
. 2012 Dec;
16(10):888-90.
PMID: 23208027
Circadian rhythmicity was repeatedly determined in a patient with Alzheimer's disease by measuring his core temperature with a rectal thermistor and motor activity by an ambulatory activity monitor. The first...
2.
3.
Volicer L, Harper D, Manning B, Goldstein R, Satlin A
Am J Psychiatry
. 2001 May;
158(5):704-11.
PMID: 11329390
Objective: The goal of this study was to determine changes of circadian rhythms induced by Alzheimer's disease and to explore relationships among rhythm disturbances, sundowning, and sleep disturbances in patients...
4.
Harper D, Stopa E, McKee A, Satlin A, Harlan P, Goldstein R, et al.
Arch Gen Psychiatry
. 2001 Apr;
58(4):353-60.
PMID: 11296096
Background: Caregiver exhaustion is a frequent consequence of sleep disturbance and rest-activity rhythm disruption that occurs in dementia. This exhaustion is the causal factor most frequently cited by caregivers in...
5.
6.
Harper D, Tornatzky W, Miczek K
Physiol Behav
. 1996 Mar;
59(3):409-19.
PMID: 8700940
Persistent autonomic disturbances following stressful events suggest that the rhythmical nature of homeostatic functioning may be disrupted by these experiences. We assessed the effects of two different stressors on circadian...
7.
Harper D, Chen C, FRIEDLAENDER M
CLAO J
. 1995 Oct;
21(4):256-60.
PMID: 8565196
We compared the safety and efficacy of MethaSite, a gel-forming suspension (0.1% fluorometholone), to a commercially available 0.1% fluorometholone ointment, FML S.O.P., using an antigen challenge model. Subjects with known...
8.
BLAYDES Jr J, Kelley E, Walt J, DeGryse R, Harper D, Novack G
J Cataract Refract Surg
. 1993 Jul;
19(4):481-7.
PMID: 8355154
We conducted a double-masked, vehicle-controlled study to evaluate the anti-inflammatory effect of topical flurbiprofen in cataract surgery by phacoemulsification and implantation of a posterior chamber intraocular lens. The 233 patients...
9.
Harper D
Surv Ophthalmol
. 1992 Sep;
37(2):151; author reply 152-3.
PMID: 1455300
No abstract available.
10.
Haas D, Young E, Harper D
J Can Dent Assoc
. 1992 Jan;
58(1):28-33.
PMID: 1531939
Malignant hyperthermia is a potentially fatal disease that may be triggered by the administration of specific drugs or by stress. Although most often associated with general anesthesia, stress can be...